baber/WOPTO huggingface dataset:
Patent AU-576497-B2 (AU)
Title: Ion test means having a hydrophilic carrier matrix
Inventor: CHARLTON STEVEN C
IPC: G01N31/22
Filed: 1984-05-10
Granted: 1988-09-01
Abstract: A test means for determining the presence of an ion in an aqueous test sample is disclosed, as well as a test device incorporating the test means, a method for preparing it and a method for using it. The test means comprises a hydrophilic carrier matrix incorporated with finely divided globules of a hydrophobic vehicle. The hydrophobic vehicle contains an ionophore capable of forming a complex with the ion, and a reporter substance capable of interacting with the complex of ionophore and ion to produce a detectable response. The test device comprises an elongated support member having an upper substantially flat face, the test means being affixed to the flat face of the support member. The method for preparing the device comprises forming a first mixture of water and a hydrophilic polymer, forming a second mixture of a hydrophobic vehicle, an ionophore capable of forming a complex with the ion, and a reporter substance capable of interacting with the complex of the ionophore and ion to produce a detectable response, combining the first and second mixtures to produce a stable emulsion of finely divided globules of the second mixture in the first mixture, coating the emulsion onto an elongated support member having an upper, substantially flat face, and evaporating the water from the emulsion to product a hydrophilic carrier matrix incorporated with finely divided globules of the second mixture, the matrix being thereby affixed to the flat face of the support member. The method for using the test means or device comprises contacting it with the test sample and observing a detectable response.
Patent AU-659243-B2 (AU)
Title: Thienopyrazine-2,3-diones and their preparation and use
Inventor: JOERGENSEN ANKER STEEN
IPC: A61P25/08
Filed: 1992-10-21
Granted: 1995-05-11
Abstract: Novel thieno(2,3-b)pyrazine-2,3(1H,3H)-diones or tautomeric forms thereof of the formula (I)  (* CHEMICAL STRUCTURE *) (I) The compounds are useful in the treatment of neurological and psychiatric diseases.
Patent AU-563647-B2 (AU)
Title: Recovering cesium from pollucite
Inventor: MEIN PETER GUENTER
IPC: C22B26/10
Filed: 1984-07-06
Granted: 1987-07-16
Abstract: Cesium is recovered from a cesium-bearing mineral such as pollucite by extraction with hydrochloric acid to obtain an extract of cesium chloride and other alkali metal and polyvalent metal chlorides. The iron and aluminum chlorides can be precipitated as the hydroxides and separated from the solution of the alkali metal chlorides to which is added potassium permanganate or other water-soluble permanganate to selectively precipitate cesium permanganate. The cesium precipitate is then separated from the residual solution containing the metal chlorides. The cesium permanganate, which is in a very pure form, can be converted to other cesium compounds by reaction with a reducing agent to obtain cesium carbonate and cesium delta manganese dioxide.
Patent AU-572204-B2 (AU)
Title: Field producing electrode for electrotherapy
Inventor: BACCHELLI LUCIANO
IPC: A61N1/20
Filed: 1984-10-12
Granted: 1988-05-05
Abstract: The instrument comprises a set of three plates 10 and 11, coplanar one with respect to the other and interspaced, the two outside ones 10 of which are connected to the negative pole of a current generator constituted by a microbattery 13, while the one in the centre, namely plate 11, is connected to the positive pole. The outside plates 10 and the central one 11 define electrodes made of metal of different characteristics, the former two zinc and the latter brass. 
<??>In this way, two different electric fields are originated: one at the surface due to the diversity in the nature of the electrodes and one deep-seated due to the auxiliary generator 13.
Patent AU-732592-B2 (AU)
Title: Method and apparatus for the non-invasive detection of medical conditions by monitoring peripheral arterial tone
Inventor: GOOR DANIEL A
IPC: A61B5/103
Filed: 1997-07-23
Granted: 2001-04-26
Abstract: A method and an apparatus for non-invasive detection of a physiological state or medical condition are disclosed. The method provides an indication of such state or condition such as myocardial ischemia or sleep apnea, by detecting the peripheral arterial tone's response to such state or condition, based on monitoring changes in peripheral arterial tone and determining that a change in the condition of the patient has occurred when a specific change in the peripheral arterial tone has been detected. A static pressure field is applied around the distal part of a digit of the subject. Peripheral arterial tone changes and related volume changes in the distal part of the digit are detected to thereby detect or monitor a physiological state or medical condition. The apparatus includes a finger probe (20), in the form of a tube (3) accommodating the patient's finger, which is designed to apply pressure, and a contiguous pressure cuff (40) which extends the boundary of the pressure field. The finger probe (2) either includes or is associated with a signal sensor/transducer (100, 101).
Patent AU-763171-B2 (AU)
Title: Antenatal screening for Down's Syndrome
Inventor: WALD NICHOLAS JOHN
IPC: G01N33/68
Filed: 1999-04-29
Granted: 2003-07-17
Abstract: A method of screening for fetal Down's syndrome is described. Screening marker levels are measured. These may be measurements of a biochemical marker in a maternal sample or measurements of a marker from an ultrasound scan. The marker levels are used to calculate a risk of Down's syndrome. Instead of using markers from a single stage of pregnancy, the method uses markers from two or more different stages of pregnancy, typically one being in the first and another being in second trimester. The method may be automated.
Patent AU-661566-B2 (AU)
Title: Apparatus and method for suture attachment
Inventor: MEADOWS BRUCE F
IPC: A61F2/08
Filed: 1993-02-10
Granted: 1995-07-27
Abstract: A cannulated bone screw is illustrated that retains a knotted suture and which is anchored to bone. The cannulated bone screw comprises a biocompatible body having a proximal end and a distal end, and the body includes exterior screw threads for inserting and retaining the body into the bone. The body is cylindrical and has a passageway that extends axially therethrough. The passageway includes a central portion, a distal portion and a proximal portion. The central portion has a diameter less then the distal portion and is sized to receive a suture thread therethrough. The distal portion is sized to receive a suture thread knot. The suture thread knot received within the distal portion is retained by the central portion, which is sufficiently small to prevent the knot from being drawn therethrough. The proximal portion includes a hexagonal cavity for cooperating with an external drive tool for rotating the body and thereby driving the body into the bone.
Patent AU-565584-B2 (AU)
Title: Residuelessly redetachable contact-adhesive sheetlike structures
Inventor: GLEICHENHAGEN PETER
IPC: C09J7/38
Filed: 1984-12-17
Granted: 1987-09-17
Abstract: Residuelessly redetachable contact-adhesive sheet-like structures wherein are provided approximately calotte-shaped bonding sites which are up to about 600  mu m in diameter at the base where the calottes stick to the sheet-like structure and which are produced by screen or gravure printing using high-solids dispersion of adhesive substance.
Patent AU-691689-B2 (AU)
Title: Hydraulic speed variator
Inventor: CANOSA REBOREDO ELENA
IPC: F16H39/32
Filed: 1995-11-06
Granted: 1998-05-21
Abstract: It comprises an integral block of a variator assembly which includes a hydropump cylinder (29), a hydromotor cylinder (39), the end-plates (30, 55) and a intermediary plate (38, 43) with ports for the fluid from the hydropump to the hydromotor at high pressure and from the hydromotor to the hydropump at low pressure to close the circuit. The shafts of the rotors (40, 50) of the hydropump and of the hydromotor have a common geometrical axis (22) which is static with respect to the outside and on which they may rotate independently, said rotation motion being the only motion possible. The variator assembly has as unique possible motion the rotation with respect to a geometrical axis (23) which is fixed with respect to the outside and different from the geometrical axis (65) of the cylinder (29) of the hydropump, different also from the geometrical axis (66) of the cylinder of the hydromotor (39) and different from the common geometrical axes (22) of the rotors. A rotation of the variator assembly is caused from the outside and causes the geometrical axes of the cylinder (29) of the hydropump and of the cylinder (39) of the hydromotor to come closer to or move away from the geometrical axes of their respective rotors (40, 50), thereby causing the variation in the ratio between the rotation speeds of the hydropump rotor (40) and the hydromotor rotor (50). <IMAGE>
Patent AU-739060-B2 (AU)
Title: Burner assemblies
Inventor: WINNINGTON TERENCE LESLIE
IPC: F23D14/14
Filed: 1997-08-08
Granted: 2001-10-04
Abstract: A burner assembly includes a number of gas burners each utilizing a radiant ceramic plaque, the burners are disposed in confined combustion chambers where they direct heat towards a heat-receiving surface so that by this arrangement the plaque receives a substantial amount of back radiation.
Patent AU-692021-B2 (AU)
Title: Composition for treatment of malignant tumors and their metastases
Inventor: RUBIN DAVID
IPC: A61K31/235
Filed: 1995-11-27
Granted: 1998-05-28
Abstract: Growth or metastasization of malignant tumors can be inhibited by administering to a patient in need thereof sufficient lactose to block crucial lectins on the affected organ so that the tumor cells cannot anchor to other locations in the body. Lactose can be administered alone, or in combination with conjugates of cytotoxic drugs. Preferably, lactose is conjugated to a cytotoxic substance so that the primary tumor is treated concurrently with prevention of metastasis. Additionally, by conjugating a cytotoxic drug to lactose, the cytotoxic drug is maintained in close proximity to the tumor because of the receptors on the tumor which bind the lactose (and therefore the cytotoxic agent bound thereto) to the tumor cells. By using a conjugate of lactose with a cytotoxic agent, one dose is generally sufficient to destroy the receptor sites on the tumor and prevent metastasis of the tumor while treating the tumor.
Patent AU-745042-B2 (AU)
Title: Methods of providing images on substrates
Inventor: HARRIS PAUL GREGORY
IPC: B42D25/328
Filed: 1999-06-09
Granted: 2002-03-07
Abstract: A method of providing an optically variable effect generating structure on a substrate. The method comprises a) providing an adhesive on the substrate; b) depositing a metal powder on the adhesive; and, c) embossing an optically variable effect generating structure into the metal powder. A method of providing an image on a substrate, the method comprising a) providing an adhesive on the substrate in a pattern corresponding to an image; and, b) depositing a metal powder on the adhesive.
Patent AU-577379-B2 (AU)
Title: Morphine derivatives
Inventor: HOFF CHRISTIAN
IPC: C07D489/00
Filed: 1985-05-24
Granted: 1988-09-22
Abstract: 1. A process for the dealkylation of 14-hydroxymorphinan alkaloids, characterized in that it consists in : 1) reacting the 14-hydroxy derivative of the formula :  see diagramm : EP0164290,P5,F6  in which R' is CH3 or COCH3 , with excess ethyl chloroformate, in the presence of potassium carbonate and in a solvent, 2) subjecting the resulting carbamate of the formula :  see diagramm : EP0164290,P5,F2  in which R' is CH3 or COCH3 , to hydrolysis in a strong acid medium to give the corresponding dealkylated derivative of the formula :  see diagramm : EP0164290,P5,F3  in which R is CH3 or hydrogen.
Patent AU-563303-B2 (AU)
Title: Proetected dipeptides
Inventor: HEAVNER GEORGE
IPC: C07K/
Filed: 1985-07-31
Granted: 1987-07-02
Abstract: Solution phase methods and compositions for preparing H-ARG-X-Z-Y-TYR-R wherein X is LYS and Y is VAL or X and Y are both SAR, Z is ASP or GLU, and R is NH<sub>2</sub> or OH.
Patent AU-626645-B2 (AU)
Title: Aerosol compositions intended for the imaging, diagnosis and targeted therapy of inflammatory and tumour foci
Inventor: HINTERLAND LUCIEN DUSSOURD D
IPC: A61K51/12
Filed: 1990-03-08
Granted: 1992-08-06
Abstract: The invention relates to an aerosol composition containing a carrier agent capable of recognising and binding to inflammatory and tumoral foci mobilising macrophages in close proximity to them, and an aerosol substrate, wherein the aforementioned carrier agent consists of a polysaccharide compound chosen from the compound D 25 extracted from the membrane proteoglycans of the Klebsiella pneumoniae bacterium and having a molecular weight of 30 +/- 10 kD, and the oxidised D 25 compound in which the galactofuranose residue (Galf) of the linear polysaccharide chain of D 25 has been converted to arabinose, and their amide, ester or ether type derivatives, as well as their quaternary ammonium derivatives and salts, and also the derivatives obtained by grafting of phosphatides.
Patent AU-520220-B2 (AU)
Title: Line amplifier coarse overvoltage protection
Inventor: POPP E
IPC: H04B3/36
Filed: 1979-10-08
Granted: 1982-01-21
Abstract: 1. A line amplifier, in particular for carrier frequency or high frequency transmission paths, comprising a circuit arrangement for coarse surge voltage protection at the input end and output end from excess voltage interference, and comprising current supply branches (2, 4 ; 9, 11) for the remote supply of the line amplifier via the cable inner conductor of the transmission path, wherein the input (E) and the output (A) of the line amplifier are d.c. coupled together via low-pass filters (2, 11) of the current supply branches (2, 4 ; 9, 11) and the d.c. connections decoupled to a cable outer conductor (13) by means of a capacitor (3, 12) at least at one point, and in particular comprising the arrangement of a choke (10) for the d.c. connection of the low-pass filters (2, 11) and decoupling of the low-pass filters (2, 11) to the cable outer conductor connection (13) on each side of the choke (10) by means of a separate capacitor (3, 12), characterized in that at least one surge voltage arrester (1) is arranged only at the input (E) of the line amplifier for coarse surge voltage protection of the input end and output end, and that the chokes (2, 11) of the current supply branches (2, 4 ; 9, 11) and further chokes (10) which are possibility arranged in the d.c. connection path between input (E) and output (A) are so designed and dimensioned that they are saturated by surge currents with slow flanks, and that the d.c. connection between the input (E) and the output (A) of the line amplifier is designed and/or wired in such manner that the voltage drop thereon is limited.
Patent AU-751174-B2 (AU)
Title: Variable angle spinal fixation system
Inventor: BRACE MICHAEL
IPC: A61B17/70
Filed: 1999-09-07
Granted: 2002-08-08
Abstract: A variable angle spinal fixation system is disclosed. The system includes a longitudinal member positionable along a spinal column, a fastener having a threaded end for engaging a vertebra, and a connector member for connecting the fastener and the longitudinal member. The connector member has a channel extending through side surfaces of the connector member for receiving the longitudinal member, an opening laterally displaced from the channel and extending through top and bottom surfaces of the connector member for receiving the fastener, and a fastener clamping element for securing the fastener in the opening at a surgeon selected angle relative to the connector member and longitudinal member. The system according to the present invention allows angulation of the fastener to accommodate complex pathologies.
Patent AU-709097-B2 (AU)
Title: Method and device for selectively heating a container preform
Inventor: EMMER GERARD
IPC: B29C35/08
Filed: 1996-04-10
Granted: 1999-08-19
Abstract: PCT No. PCT/FR96/00538 Sec. 371 Date Dec. 16, 1997 Sec. 102(e) Date Dec. 16, 1997 PCT Filed Oct. 10, 1996 PCT Pub. No. WO96/32243 PCT Pub. Date Oct. 17, 1996A preform (3) for use in making a container such as a bottle from a thermoplastic material is selectively heated prior to at least one step of blow molding or stretch-blow molding the heated preform. For this purpose, at least most (7A) of the radiation (4) transmitted generally towards the preform by a source (1A) is focused (8) onto a preferred area (A) thereof, the source is located substantially opposite the preferred area of the preform, whereby said the preferred area (A) receives most (7A) of the radiation (4) while the areas adjacent to the preferred area (A) do not receive the radiation fraction initially transmitted towards them by the source.
Patent AU-701279-B2 (AU)
Title: Peptide compounds which inhibit metalloproteinase and TNF liberation and their therapeutic uses
Inventor: BAXTER ANDREW DOUGLAS
IPC: A61P29/00
Filed: 1996-05-10
Granted: 1999-01-21
Abstract: Tripeptidyl derivatives having a SH or acylS group and which are amides, have therapeutic utility via MMP or TNF inhibition.
Patent AU-630048-B2 (AU)
Title: Polymer base blend compositions containing destructurized starch
Inventor: SACHETTO JEAN-PIERRE
IPC: C08L39/04
Filed: 1990-07-11
Granted: 1992-10-15
Abstract: A composition of matter capable of being formed into articles having substantial dimensional stability comprising     a) destructurized starch, and b) at least one compound selected from the group consisting of polyalkyleneimine polymers and polyalkyleneimine copolymers; said modified polysaccharide being present in an amount effective to enhance the physical properties of said articles.   The composition may contain further conventional additives as well as hydrophobic, substantially water-insoluble polymers.
Patent AU-760688-B2 (AU)
Title: Pyrazolo-triazine derivatives as ligands for GABA receptors
Inventor: CARLING WILLIAM ROBERT
IPC: A61K31/53
Filed: 1999-10-13
Granted: 2003-05-22
Abstract: Compounds according to Formula (I):or a salt or prodrug thereof, have good affinity as ligands for the alpha2 and/or alpha3 subunit of the human GABAA receptor and are useful for treatment of disorders of the central nervous system, including anxiety and convulsions.
Patent AU-601160-B2 (AU)
Title: Method and plant for tartars separation
Inventor: OHTA NAOTAKE
IPC: C12H1/06
Filed: 1986-09-23
Granted: 1990-09-06
Abstract: A cylindrical crystallizer has a draft tube which is centered in the lower half of the crystallizer. In the crystallizer, there is a circulation for crystallization consisting of a downward flow inside the draft tube and an upward flow outside the draft tube. The downward flow is produced by a stirrer. In the zone above the circulation, the upward flow rate is low, forming a calming section. The calming section facilitates classification of the tartar crystals. Product from which tartar has been removed is overflowed.
Patent AU-535337-B2 (AU)
Title: Hydroxyl containing styrene copolymers
Inventor: FISCHER HANNES
IPC: C08F220/06
Filed: 1980-10-17
Granted: 1984-03-15
Abstract: A process for the preparation of copolymers containing hydroxyl groups by radical reaction of (A) 10 to 30% by weight of at least one glycidyl ester containing 12 to 14 carbon atoms, of an aliphatic saturated monocarboxylic acid with a tertiary or quaternary  alpha -carbon atom; and (B) 90 to 70% by weight of at least two unsaturated copolymerisable monomers, at least one of which contains at least one carboxyl group, wherein component (A) is introduced first to a reaction zone and is then reacted at a temperature of at least 140 DEG  C. with component (B) and a radical initiator, the component (B) containing a monomer having carboxyl groups, wherein for the preparation of low-viscosity copolymers component (A) is reacted at 140 to 200 DEG  C. by substance polymerisation until a degree of reaction of at least 95% is achieved, the component (B) containing at least 3.3% by weight of the monomer having carboxyl groups, and an article coated with a product of said process.
Patent AU-634280-B2 (AU)
Title: Anticoagulant peptides
IPC: A61K38/00
Filed: 1990-10-01
Granted: 1993-02-18
Abstract: This invention relates to peptide derivatives which are useful anticoagulant agents.
Patent AU-593848-B2 (AU)
Title: Moulded fibre reinforced plastic articles
Inventor: WILLIS ANTHONY JOHN
IPC: B29K105/06
Filed: 1986-10-31
Granted: 1990-02-22
Abstract: A process for moulding articles of fibre reinforced plastics material which includes pre-heating a sheet of consolidated thermoplastics material which has dispersed therein from 20% to 70% by weight of reinforcing fibres which have a high modulus of elasticity (as herein defined) and between about 7 and about 50 millimetres long to cause the sheet to expand due to relief of the stresses in the reinforcing fibres, placing the expanded sheet in a com­pression mould and closing the mould to form an article of predetermined shape having portions of different density.
Patent AU-725368-B2 (AU)
Title: Form III crystalline (R-(R*,R*)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5- (1-methyl-ethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H- pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
Inventor: MCKENZIE ANN T
IPC: A61K31/40
Filed: 1996-07-08
Granted: 2000-10-12
Abstract: A novel crystalline form of [(R-(R*,R*)]-2-(4-fluorophenyl)- beta , delta -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form III is characterized by its X-ray powder diffraction and/or solid state NMR is described, as well as methods for the preparation and pharmaceutical composition of the same, which is useful as an agent for treating hyperlipidemia and hypercholesterolemia.
Patent AU-548290-B2 (AU)
Title: Para-substituted 3-phenoxy-1-alkylamino-propan-2-01 beta receptor blocking compounds
Inventor: CARLSSON ENAR INGEMAR
IPC: A61K31/22
Filed: 1981-05-29
Granted: 1985-12-05
Abstract: The present invention relates to new compounds of the formula I <CHEM> as well as their preparation, pharmaceutical preparations containing same, and method of treating acute myocardial infarction. The compounds which possess beta-adrenoceptor blocking activity are very shortacting and are intended for treatment of acute myocardial infarction by administration by means of injection.
Patent AU-695311-B2 (AU)
Title: Gamma-RAR antagonist ligand or alpha-RAR agonist ligand as an apoptosis inhibitor
Inventor: FESUS LASZLO
IPC: A61P25/00
Filed: 1996-10-08
Granted: 1998-08-13
Abstract: PCT No. PCT/FR96/01569 Sec. 371 Date Jul. 15, 1998 Sec. 102(e) Date Jul. 15, 1998 PCT Filed Oct. 8, 1996 PCT Pub. No. WO97/13506 PCT Pub. Date Apr. 17, 1997The use of a combination of an alpha RAR receptor-specific agonist ligand and a gamma RAR receptor-specific antagonist ligand to reduce the rate of apoptosis is disclosed.
Patent AU-544696-B2 (AU)
Title: Pneumatic transport of pulvenilent materials
Inventor: ULVELING LEON
IPC: B65G53/46
Filed: 1981-06-29
Granted: 1985-06-13
Abstract: 1. Method for the uniform pneumatic conveyance of finely dived materials which are introduced into a carrier gas by means of a rotary valve, the carrier gas being guided through the rotor of the rotary valve in a direction parallel to the rotation axis of the latter, characterized in that the pneumatic current of finely divided materials is disturbed "downstream" from the rotary valve by reducing the speed of circulation of said current over a certain traject and causing a fluidized bed t form therein from the pulverulent material of the pneumatic current.
Patent AU-632907-B2 (AU)
Title: Novel ascorbic acid derivatives
IPC: A61P3/06
Filed: 1991-03-14
Granted: 1993-01-14
Abstract: This invention relates to derivatives of certain 3,4-dihydroxy-2,5-dihydrofuran-5-ones, to the intermediates and processes useful for their preparation, to their free-radical scavenger and cellular protective properties, and to their end-use application as therapeutic agents.